Apitegromab

阿匹特古单抗

Report date: 2026/05/02 20:00:18

Base Information

Drug NameApitegromab
Drug Alias NameSRK-015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsOverweightAtrophyObesity +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[9
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesScholar Rock Inc
China Registration ClassN/A

Develop Information

Active CompaniesScholar Rock Inc
Inactive CompaniesN/A
Active IndicationsOverweightAtrophyObesity +[9
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG